MSHLMeta-iodobenzylguanidine [I-131] Injection For Therapeutic Use 185 to 740 MBq/mL
Radiation therapy of tumours arising from cells originating embryologically from the neural crest, pheochromocytomas, neuroblastomas, carcinoids and medullary carcinomas of the thyroid gland.